Cervical Cancer: Real Pictures and What They Show

Images of cervical cancer and its precursors span a wide range of appearances depending on the stage of disease and the tool used to capture the picture. A healthy cervix typically looks smooth and uniformly pink, while precancerous lesions show up as white patches, unusual blood vessel patterns, or areas that refuse to absorb diagnostic stains. By the time cervical cancer becomes invasive, it can appear as a visible mass, an ulcer, or a distorted cervical surface that bleeds easily. Understanding what each of these visual clues means helps demystify the screenings and biopsy results that many people find confusing or frightening.

What a Healthy Cervix Looks Like

During a routine pelvic exam or colposcopy, the cervix appears as a rounded, pinkish structure at the top of the vaginal canal. Its surface is covered in smooth squamous epithelium, similar to the skin lining the inside of your cheek. At the center is the os, the small opening that leads into the uterine cavity. Around the os is a region called the transformation zone, where one cell type gradually converts into another. This zone is important because it is the most common site where abnormal cells develop.

The transformation zone exists because the inner cervical canal is lined with a different type of tissue, columnar epithelium, which has a redder, more granular texture. Over time, columnar cells at the junction are replaced by squamous cells in a normal process. Practically every screening method, whether a Pap smear, colposcopy, or biopsy, focuses on sampling this zone because it is where the action happens, both normal cell turnover and the earliest stages of disease.

Benign Conditions That Can Look Alarming

Not every unusual-looking cervix signals cancer. Several common conditions can appear red, bumpy, or irregular and still be completely harmless. Knowing about them can save you a lot of unnecessary worry after a visual exam.

Cervical ectropion (sometimes called cervical erosion) is one of the most frequently misidentified findings. It occurs when the redder columnar cells from the inner canal extend outward onto the visible surface of the cervix. This makes the cervix look raw or inflamed, but it is usually a normal variant, especially common in younger people and those taking hormonal contraceptives. One study found ectropion in about a third of women with high-grade cervical dysplasia compared to roughly 10 percent of controls, suggesting that while ectropion itself is benign, it may be more frequently associated with environments where abnormal cell changes develop.¹ Still, the presence of ectropion alone does not mean anything dangerous is happening.

Nabothian cysts are another common finding. These are small, smooth, yellowish or whitish bumps on the cervix caused by blocked mucus glands. They look a bit like tiny blisters, and they are entirely benign. Small cervical polyps, which are fleshy growths protruding from the os, can also look worrisome but are almost always non-cancerous. A clinical review in Mayo Clinic Proceedings noted that ectropion, Nabothian cysts, and small polyps are benign findings that need not generate concern, while features like persistent inflammation, abnormal Pap results, or bleeding after intercourse should prompt further investigation.²

What Precancerous Changes Look Like During Colposcopy

Colposcopy is essentially a magnified visual exam of the cervix. The clinician applies a dilute acetic acid solution (basically vinegar) to the cervix and views it through a low-powered microscope. This step is where many of the clinical images people encounter online originate.

When acetic acid contacts abnormal cells, those cells temporarily turn white, a reaction called acetowhitening. Normal tissue stays pink or only slightly changes. The density and opacity of the white color correlate roughly with how abnormal the underlying cells are. A faint, translucent whiteness might suggest mild changes, while a thick, opaque white patch with sharp borders is more concerning for a high-grade precancerous lesion.

Beyond color changes, clinicians look at blood vessel patterns. Normal cervical vessels are fine and evenly distributed. As cells become more abnormal, the vessels can rearrange into recognizable patterns. Punctation refers to tiny red dots visible on the surface, created by vessels viewed end-on. Mosaicism describes a tiled or cobblestone pattern where vessels outline small blocks of tissue. When vessels become irregular, branching unpredictably with abrupt caliber changes, clinicians call them atypical vessels, and this finding raises more serious suspicion. A study analyzing factors influencing colposcopy biopsy accuracy found that atypical blood vessels and the visible lesion area were independent factors affecting how well a biopsy detected precancerous and cancerous changes.³

In that same study, the agreement between colposcopy-guided biopsy results and subsequent surgical pathology was about 79 percent. Roughly one in ten cases was upgraded on final pathology, meaning the disease turned out to be more advanced than the biopsy initially suggested. This is why colposcopy images are considered a guide rather than a definitive diagnosis: they tell the clinician where to biopsy, and the tissue sample tells the rest of the story.³

Iodine Staining and What the Colors Mean

In settings where colposcopy equipment is unavailable, or as a complement to it, clinicians sometimes apply Lugol’s iodine solution directly to the cervix. This technique is called VILI (Visual Inspection with Lugol’s Iodine). Healthy squamous cells contain glycogen, which reacts with iodine to turn a dark mahogany brown. Abnormal or precancerous cells have depleted glycogen stores, so they fail to take up the stain and remain mustard yellow or pale. The contrast can be dramatic: a dark brown cervix with a sharply defined pale patch is a visual red flag.⁴

Partial uptake, producing a yellowish-brown color, is considered negative, while complete non-uptake (bright mustard yellow) is considered positive for possible abnormality. The iodine test does not diagnose cancer by itself, but it helps clinicians rapidly identify areas that need biopsy, especially in resource-limited settings where sophisticated imaging is not available. Images from VILI exams are some of the most visually striking clinical photographs because the color difference between healthy and abnormal tissue is so obvious.

What Pathologists See Under the Microscope

While colposcopy and staining tests show the surface of the cervix, the real diagnostic power comes from examining biopsied tissue under a microscope. This is where the grading of precancerous lesions happens, and the images at this level look very different from anything you would see during a clinical exam.

One of the hallmark microscopic features of HPV infection in cervical tissue is the koilocyte. Koilocytes are squamous cells with a distinctively shrunken, darkened nucleus pushed off to one side by a large clear halo. These cells look like tiny fried eggs under magnification. Their presence is considered a signature of HPV infection because the viral proteins cause the cell’s internal architecture to collapse in this characteristic way.⁵ In Pap smears and biopsies, these koilocytic changes are one of the features used to classify low-grade squamous intraepithelial lesions (LSIL).⁶

Not every HPV-related change produces classic koilocytes, though. Some infections cause subtler, non-classical cellular changes that can be harder to spot. One study categorized HPV-related findings on Pap smears and found that non-classical changes were four times more common than the classic koilocytic pattern, occurring in 120 women versus 30 with classical changes.⁷ This is one reason why visual screening alone, whether at the colposcopy level or the microscopic level, is supplemented by molecular testing like HPV DNA assays.

As precancerous changes become more severe, the microscopic picture shifts. In low-grade lesions, abnormal cells are confined to the lower third of the tissue layer. In high-grade lesions (HSIL or CIN 2-3), abnormal cells occupy most or all of the epithelial thickness. The cells look increasingly disordered, with larger, irregular nuclei and frequent cell division figures visible even in the upper layers where mature cells should dominate. Pathologists grade the severity based on how much of the tissue thickness is involved and how disordered the cells appear.

Biomarkers That Help Pathologists Interpret What They See

Microscopic appearance alone sometimes leaves room for ambiguity, especially in borderline cases. Pathologists increasingly rely on protein markers detected through special staining techniques to improve diagnostic accuracy. Two of the most widely used are p16 and Ki-67.

The p16 protein is overproduced when HPV’s cancer-causing genes are active in a cell. Under the microscope, p16 staining shows up as a strong brown or reddish-brown color in affected cells. When the staining is diffuse and block-like across the tissue, it strongly suggests a high-grade lesion. Ki-67 is a marker of cell proliferation: it is present in cells that are actively dividing. In normal cervical tissue, actively dividing cells are confined to the base layer. When Ki-67 staining lights up across the full thickness of the epithelium, it tells the pathologist that abnormal proliferation is occurring throughout the tissue.

Research has shown that p16 and Ki-67 expression increases steadily from normal tissue through low-grade lesions to high-grade lesions and invasive cancer, and that these markers improve the accuracy of cervical lesion diagnosis.⁸ A more recent study confirmed that the expression patterns of p16, Ki-67, and another marker called p63 correlate with lesion severity and help distinguish low-grade from high-grade and invasive disease.⁹ In practical terms, when your biopsy report mentions p16-positive staining, it gives the pathologist more confidence in grading the lesion.

How Pap Smears Match Up With What Biopsies Find

Pap smears are the most familiar screening tool, and the images produced are among the most widely circulated in public health materials. Under the microscope, a Pap smear shows individual cells scraped from the cervix, spread on a slide, and stained. Normal cells look small and uniform with well-organized nuclei. Abnormal cells show the range of changes already described: enlarged or irregular nuclei, koilocytic halos, crowded clusters of immature-looking cells.

But Pap smears are a screening test, not a definitive diagnosis. Their accuracy varies with the severity of the abnormality. Data from an accredited cytology laboratory showed that Pap smears matched biopsy findings 100 percent of the time for confirmed squamous cell carcinoma, about 82 percent for high-grade lesions, and only about 66 percent for low-grade lesions.¹⁰ In other words, Pap smears are excellent at catching the most serious changes but can miss or misclassify milder ones. This is why an abnormal Pap result leads to colposcopy and biopsy rather than immediate treatment: the screening image raises a flag, and the tissue sample confirms the finding.

What Invasive Cervical Cancer Looks Like

When precancerous changes progress beyond the surface layer and invade deeper tissue, the appearance changes dramatically. At the gross visual level, during a speculum exam or colposcopy, invasive cervical cancer can present in several ways. Some tumors grow outward as raised, irregular masses with a cauliflower-like texture (exophytic growth). Others burrow inward, creating a barrel-shaped cervix that feels firm on examination. Ulcerative forms show a crater-like erosion on the cervical surface, often with bleeding on contact. Some advanced cancers produce a necrotic, friable surface that bleeds spontaneously.

Under the microscope, the picture depends on the type of cancer. Squamous cell carcinoma, the most common type, shows nests and sheets of abnormal squamous cells pushing into the surrounding tissue. A large international study of 670 cases found a wide range of growth patterns in squamous cell carcinoma, including both HPV-associated and HPV-independent subtypes, each with distinct microscopic features that can complicate diagnosis. Interestingly, the specific growth pattern had limited value in predicting patient outcomes.¹¹ Adenocarcinoma, the second most common type, arises from the glandular columnar cells and has a different microscopic architecture, forming abnormal gland-like structures.

At this stage, clinical images often show a cervix that is clearly abnormal even to a non-specialist: large irregular masses, visible ulceration, or surfaces that bleed when touched with a swab. These images look quite different from the subtle white patches or vessel pattern changes seen in precancerous stages.

MRI and Staging of Advanced Disease

Once invasive cancer is confirmed, imaging shifts from the cervix itself to the surrounding anatomy. MRI is the primary tool for assessing how far the cancer has spread locally. On MRI, cervical tumors typically appear as areas of altered signal intensity within the normal cervical tissue. The key question at this stage is whether the cancer has extended into the parametrium, the connective tissue surrounding the cervix that contains blood vessels, nerves, and lymphatic channels.

Researchers have mapped the parametrial anatomy on MRI to better identify routes of local disease spread, including anterior, posterior, and lateral extensions. This detailed anatomical mapping helps surgeons and radiation oncologists plan treatment by showing exactly where the tumor’s borders reach.¹² For the patient, what this means in practical terms is that MRI images help determine whether surgery is feasible or whether radiation therapy is the better approach. Parametrial invasion is one of the key findings that shifts treatment planning.

AI-Assisted Visual Screening

One of the more recent developments in cervical cancer imaging is the use of artificial intelligence to analyze photographs of the cervix taken during screening. The concept, known as automated visual evaluation (AVE), uses deep-learning algorithms trained on thousands of cervical images to classify what they see. The idea is especially appealing in settings where trained colposcopists are scarce.

For AVE to be worth adopting, researchers have noted that it would need to consistently outperform unaided visual inspection as practiced in the field and perform at least as well as expert colposcopists.¹³ Validation studies are underway. In one study in Zambia, an AI-based AVE system was combined with HPV genotyping, and the AVE classification showed good reproducibility and added finer predictive accuracy to each HPV type group. The system strongly predicted diagnostic findings even in women living with HIV, who have a higher prevalence of precancerous and cancerous lesions.¹⁴

Another emerging imaging technology is optical coherence tomography (OCT), which works somewhat like an ultrasound but uses light instead of sound to produce cross-sectional images of tissue in real time. OCT can visualize the layered structure of cervical tissue without cutting into it, revealing whether the normal layered architecture is disrupted. In a multi-center clinical study, OCT achieved roughly 87 percent sensitivity and 84 percent specificity for detecting cervical lesions, with an overall accuracy of about 85 percent.¹⁵ A separate study found that combining HPV testing with OCT yielded higher specificity than combining HPV testing with traditional cytology for detecting high-grade lesions.¹⁶ OCT images look like grayscale cross-sections, showing distinct tissue layers that correspond well with what pathologists see on traditional biopsy slides.

Why Precancerous Lesions Do Not Always Progress

One thing that images alone cannot tell you is what a given lesion will do next. Many people see images of precancerous changes and assume they inevitably lead to cancer. In reality, the majority of low-grade lesions regress on their own as the immune system clears the underlying HPV infection. Even among lesions classified as CIN 1 or CIN 2, only a fraction progress to more advanced disease. One prospective study following CIN 1 and CIN 2 lesions found that about 11 percent progressed during follow-up, while the rest either stayed the same or regressed.¹⁷ The presence of high-risk HPV types in the lesion was one factor that distinguished those more likely to progress.

This is an important piece of context when looking at clinical images. A photograph of an acetowhite patch on the cervix, or a biopsy slide labeled CIN 1, does not by itself mean cancer is developing. It means the tissue needs monitoring. Clinicians use a combination of the visual findings, the HPV type involved, the biopsy grade, and sometimes biomarker results to decide whether to watch and wait or to treat. The images are a critical first step in that decision process, but they are never the whole story.